High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma

Renal cell carcinoma (RCC) patients frequently have increased number of immunosuppressive myeloid cells in circulation. High number of myeloid-derived suppressor cells (MDSCs) in the blood are associated with immune suppression as well as with cancer-related inflammation which drives the mobilizati...

Full description

Bibliographic Details
Main Authors: Sergei Kusmartsev, Elizabeth Kwenda, Paul R. Dominguez-Gutierrez, Paul L. Crispen, Padraic O’Malley
Format: Article
Language:English
Published: Codon Publications 2022-04-01
Series:Journal of Kidney Cancer and VHL
Subjects:
Online Access:https://jkcvhl.com/index.php/jkcvhl/article/view/208
_version_ 1811234127771336704
author Sergei Kusmartsev
Elizabeth Kwenda
Paul R. Dominguez-Gutierrez
Paul L. Crispen
Padraic O’Malley
author_facet Sergei Kusmartsev
Elizabeth Kwenda
Paul R. Dominguez-Gutierrez
Paul L. Crispen
Padraic O’Malley
author_sort Sergei Kusmartsev
collection DOAJ
description Renal cell carcinoma (RCC) patients frequently have increased number of immunosuppressive myeloid cells in circulation. High number of myeloid-derived suppressor cells (MDSCs) in the blood are associated with immune suppression as well as with cancer-related inflammation which drives the mobilization of myeloid cells to tumor tissue. Here, we show that peripheral blood from a previously untreated RCC patient has increased the number of monocytic CD33+CD11b+ MDSCs, which also co-expressed PD-L1 and membrane-bound enzyme hyaluronidase 2 (Hyal2). PD-L1 expression is associated with immune suppression, whereas expression of Hyal2 is associated with inflammation, because Hyal2+ myeloid cells can degrade the extracellular hyaluronan (HA), leading to the accumulation of pro-inflammatory HA fragments with low molecular weight. These findings implicate the potential involvement of monocytic MDSCs in both tumor-associated immune suppression and cancer-related inflammation. Analysis of organotypic tumor-tissue slice cultures prepared from cancer tissue of the same patient revealed the significant presence of PD-L1+ HLA-DR+ macrophage-like or dendritic cell-like antigen-presenting cells in tumor stroma. Interestingly, stroma-associated PD-L1+ cells frequently have intracellular hyaluronan. Collectively, data presented in this study suggest that the interplay between tumor-recruited myeloid cells and stromal HA may contribute to the inflammation and immune tolerance in kidney cancer.
first_indexed 2024-04-12T11:31:26Z
format Article
id doaj.art-b4bfdd8a3a5f4164a440fd2371c2653d
institution Directory Open Access Journal
issn 2203-5826
language English
last_indexed 2024-04-12T11:31:26Z
publishDate 2022-04-01
publisher Codon Publications
record_format Article
series Journal of Kidney Cancer and VHL
spelling doaj.art-b4bfdd8a3a5f4164a440fd2371c2653d2022-12-22T03:35:01ZengCodon PublicationsJournal of Kidney Cancer and VHL2203-58262022-04-019210.15586/jkcvhl.v9i2.208High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell CarcinomaSergei Kusmartsev0Elizabeth Kwenda1Paul R. Dominguez-Gutierrez2Paul L. Crispen3Padraic O’Malley4Department of Urology, University of Florida, Gainesville, FL, USA.Department of Urology, University of Florida, Gainesville, FL, USA.Department of Urology, University of Florida, Gainesville, FL, USA.Department of Urology, University of Florida, Gainesville, FL, USA.Department of Urology, University of Florida, Gainesville, FL, USA. Renal cell carcinoma (RCC) patients frequently have increased number of immunosuppressive myeloid cells in circulation. High number of myeloid-derived suppressor cells (MDSCs) in the blood are associated with immune suppression as well as with cancer-related inflammation which drives the mobilization of myeloid cells to tumor tissue. Here, we show that peripheral blood from a previously untreated RCC patient has increased the number of monocytic CD33+CD11b+ MDSCs, which also co-expressed PD-L1 and membrane-bound enzyme hyaluronidase 2 (Hyal2). PD-L1 expression is associated with immune suppression, whereas expression of Hyal2 is associated with inflammation, because Hyal2+ myeloid cells can degrade the extracellular hyaluronan (HA), leading to the accumulation of pro-inflammatory HA fragments with low molecular weight. These findings implicate the potential involvement of monocytic MDSCs in both tumor-associated immune suppression and cancer-related inflammation. Analysis of organotypic tumor-tissue slice cultures prepared from cancer tissue of the same patient revealed the significant presence of PD-L1+ HLA-DR+ macrophage-like or dendritic cell-like antigen-presenting cells in tumor stroma. Interestingly, stroma-associated PD-L1+ cells frequently have intracellular hyaluronan. Collectively, data presented in this study suggest that the interplay between tumor-recruited myeloid cells and stromal HA may contribute to the inflammation and immune tolerance in kidney cancer. https://jkcvhl.com/index.php/jkcvhl/article/view/208renal cell carcinomacancer immune microenvironmentmyeloid-derived suppressor cellsHyal2
spellingShingle Sergei Kusmartsev
Elizabeth Kwenda
Paul R. Dominguez-Gutierrez
Paul L. Crispen
Padraic O’Malley
High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma
Journal of Kidney Cancer and VHL
renal cell carcinoma
cancer immune microenvironment
myeloid-derived suppressor cells
Hyal2
title High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma
title_full High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma
title_fullStr High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma
title_full_unstemmed High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma
title_short High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma
title_sort high levels of pd l1 and hyal2 myeloid derived suppressor cells in renal cell carcinoma
topic renal cell carcinoma
cancer immune microenvironment
myeloid-derived suppressor cells
Hyal2
url https://jkcvhl.com/index.php/jkcvhl/article/view/208
work_keys_str_mv AT sergeikusmartsev highlevelsofpdl1andhyal2myeloidderivedsuppressorcellsinrenalcellcarcinoma
AT elizabethkwenda highlevelsofpdl1andhyal2myeloidderivedsuppressorcellsinrenalcellcarcinoma
AT paulrdominguezgutierrez highlevelsofpdl1andhyal2myeloidderivedsuppressorcellsinrenalcellcarcinoma
AT paullcrispen highlevelsofpdl1andhyal2myeloidderivedsuppressorcellsinrenalcellcarcinoma
AT padraicomalley highlevelsofpdl1andhyal2myeloidderivedsuppressorcellsinrenalcellcarcinoma